Cargando…

Quality of life in ambulatory pulmonary arterial hypertension in connective tissue diseases and its relationship with risk stratification

The Pulmonary Arterial Hypertension Symptoms and Impact Questionnaire (PAH-SYMPACT) is a PAH-specific patient-reported outcome scale assessing patients’ quality of life from four aspects: cardiopulmonary symptoms, cardiovascular symptoms, physical impacts and cognitive/emotional impacts. This study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Yue, Meng, Yanling, Dong, Xingbei, Liu, Yang, Liu, Yongtai, Lai, Jinzhi, Tian, Zhuang, Zhao, Jiuliang, Peng, Jinmin, Wang, Qian, Li, Mengtao, Zeng, Xiaofeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278470/ https://www.ncbi.nlm.nih.gov/pubmed/34290858 http://dx.doi.org/10.1177/20458940211029899

Ejemplares similares

Cross-cultural validation of the Chinese version of the EmPHasis-10 questionnaire in connective tissue disease patients with pulmonary arterial hypertension and its relationship with risk stratification
por: Shi, Yue, et al.
Publicado: (2022)

Right Ventricle to Pulmonary Artery Coupling Predicts the Risk Stratification in Patients With Systemic Sclerosis-Associated Pulmonary Arterial Hypertension
por: Lai, Jinzhi, et al.
Publicado: (2022)

Diversity of hemodynamic types in connective tissue disease associated pulmonary hypertension: more than a subgroup of pulmonary arterial hypertension
por: Dong, Xingbei, et al.
Publicado: (2022)

Baseline Characteristics and Risk Factors of Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus Patients
por: Huang, Can, et al.
Publicado: (2016)

The diagnostic and prognostic value of growth differentiation factor‐15 in systemic lupus erythematosus‐associated pulmonary arterial hypertension
por: Qian, Junyan, et al.
Publicado: (2023)

2020 Chinese Expert-based Consensus on the Diagnosis and Treatment of Connective Tissue Disease Associated Pulmonary Arterial Hypertension
por: Zhao, Jiuliang, et al.
Publicado: (2021)

Impact of pregnancy in patients with systemic lupus erythematosus-associated pulmonary arterial hypertension: case series and literature review
por: Li, Mucong, et al.
Publicado: (2022)

Validation of the REVEAL Prognostic Models in Systemic Lupus Erythematosus-Associated Pulmonary Arterial Hypertension
por: Qu, Jingge, et al.
Publicado: (2021)

Risk assessment in systemic lupus erythematosus-associated pulmonary arterial hypertension: CSTAR-PAH cohort study
por: Wang, Qian, et al.
Publicado: (2022)

Myocardial involvement is not rare in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis/clinically amyopathic dermatomyositis: a retrospective study
por: Zhou, Shuang, et al.
Publicado: (2022)

A prognostic model for systemic lupus erythematosus-associated pulmonary arterial hypertension: CSTAR-PAH cohort study
por: Qu, Jingge, et al.
Publicado: (2023)

Identification of potential susceptibility genes in patients with primary Sjögren’s syndrome-associated pulmonary arterial hypertension through whole exome sequencing
por: Li, Mucong, et al.
Publicado: (2023)

Efficacy and safety of ambrisentan in Chinese patients with connective tissue disease-pulmonary arterial hypertension: a post-hoc analysis
por: Li, Mengtao, et al.
Publicado: (2020)

Novel biomarkers for risk stratification in pulmonary arterial hypertension
por: Zelniker, Thomas, et al.
Publicado: (2015)

Risk stratification and medical therapy of pulmonary arterial hypertension
por: Galiè, Nazzareno, et al.
Publicado: (2019)

Risk Stratification in Pulmonary Arterial Hypertension, Update and Perspectives
por: Vraka, Argyro, et al.
Publicado: (2023)

The Right Heart Network and Risk Stratification in Pulmonary Arterial Hypertension
por: Haddad, Francois, et al.
Publicado: (2022)

Risk Stratification of Patients with Pulmonary Arterial Hypertension: The Role of Echocardiography
por: Mercurio, Valentina, et al.
Publicado: (2022)

Recurrent Non-stroke Central Neurologic Manifestations in Primary Antiphospholipid Syndrome
por: You, Hanxiao, et al.
Publicado: (2022)

New insights into the pathogenesis and management of rheumatoid arthritis
por: Jin, Shangyi, et al.
Publicado: (2022)

Vision Loss, Multiple Cerebral Infarction, Ischemia of Extremities: Systemic Vasculitis or Cardiac Myxoma?
por: Wang, Li, et al.
Publicado: (2020)

Pulmonary Arterial Remodeling Is Related to the Risk Stratification and Right Ventricular-Pulmonary Arterial Coupling in Patients With Pulmonary Arterial Hypertension
por: Grignola, Juan C., et al.
Publicado: (2021)

Clinical Characteristics and Prognoses of Patients With Systemic Lupus Erythematosus Hospitalized for Pulmonary Infections
por: Yang, Yanli, et al.
Publicado: (2021)

Advanced risk stratification of intermediate risk group in pulmonary arterial hypertension
por: Yogeswaran, Athiththan, et al.
Publicado: (2020)

Risk Stratification in Pulmonary Arterial Hypertension: Do Not Forget the Patient Perspective
por: Humbert, Marc, et al.
Publicado: (2021)

Interpretation of Ambulatory Blood Pressure Monitoring for Risk Stratification in Hypertensive Patients: The ‘Ambulatory Does Prediction Valid (ADPV)’ Approach
por: Angeli, Fabio, et al.
Publicado: (2023)

Anti-SmD1 antibodies are associated with renal disorder, seizures, and pulmonary arterial hypertension in Chinese patients with active SLE
por: Hu, Chaojun, et al.
Publicado: (2017)

The Challenges and Future Perspective for the Management of Systemic Lupus Erythematosus in China: A Concise Annual Report of 2020
por: Tian, Xinping, et al.
Publicado: (2022)

The Growing Role of Echocardiography in Pulmonary Arterial Hypertension Risk Stratification: The Missing Piece
por: Miotti, Cristiano, et al.
Publicado: (2021)

Risk stratification in adult and pediatric pulmonary arterial hypertension: A systematic review
por: Lokhorst, Chantal, et al.
Publicado: (2022)

Factors determining change in treatment for ambulatory children with pulmonary arterial hypertension: Implications for monitoring
por: Critser, Paul J., et al.
Publicado: (2022)

2022 Chinese guideline for the management of pregnancy and reproduction in systemic lupus erythematosus
por: Tian, Xinping, et al.
Publicado: (2023)

Mesenchymal stem cells and connective tissue diseases: From bench to bedside
por: Shi, Yue, et al.
Publicado: (2022)

Connective tissue disease-associated pulmonary arterial hypertension
por: Condliffe, Robin, et al.
Publicado: (2015)

Against the Odds: Risk Stratification with Cardiac Magnetic Resonance Imaging in Pulmonary Arterial Hypertension
por: Richter, Manuel J., et al.
Publicado: (2020)

Identification of Cardiac Magnetic Resonance Imaging Thresholds for Risk Stratification in Pulmonary Arterial Hypertension
por: Lewis, Robert A., et al.
Publicado: (2020)

Imaging and Risk Stratification in Pulmonary Arterial Hypertension: Time to Include Right Ventricular Assessment
por: Alandejani, Faisal, et al.
Publicado: (2022)

The efficacy of Mycophenolate mofetil for the treatment of Chinese Takayasu’s arteritis
por: Li, Jing, et al.
Publicado: (2016)

Early Initiation of Anticoagulation Improves the Long-Term Prognosis in Patients With Antiphospholipid Syndrome Associated Portal Vein Thrombosis
por: You, Hanxiao, et al.
Publicado: (2021)

Immune Thrombocytopenia Could be an Independent Clinical Phenotype of Antiphospholipid Syndrome: A Prospective Cohort Study
por: Shi, Yu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_odnc6cvvfqs7n85t64gf17ar8r